Trials / Completed
CompletedNCT01386996
Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler
Pharmacokinetic Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 320/9 Microg/Inhalation and Symbicort Turbuhaler Forte; a Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide/formoterol Easyhaler 320/9 microg | 2 inhalations as a single dose |
| DRUG | Symbicort Turbuhaler forte | 2 inhalations as a single dose |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2011-07-01
- Last updated
- 2011-12-22
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01386996. Inclusion in this directory is not an endorsement.